# A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece

> **NCT06185660** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 125 (actual)

## Conditions studied

- Hyperkalaemia

## Interventions

- **DRUG:** sodium zirconium cyclosilicate (SZC)

## Key facts

- **NCT ID:** NCT06185660
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-09
- **Primary completion:** 2025-01-03
- **Final completion:** 2025-01-03
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06185660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06185660, "A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06185660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*